CUE 501
Alternative Names: CUE-501Latest Information Update: 29 Jul 2024
At a glance
- Originator Cue Biopharma
- Class Anti-inflammatories; Bispecific antibodies; Immunotherapies; Recombinant fusion proteins
- Mechanism of Action B cell inhibitors; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autoimmune disorders; Inflammation